SCHEMBL28564

SCHEMBL28564

C1CC2CCN(C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24409361 1.00
Hydrochloric Acid SCHEMBL3339719 0.97 CHRNA7 (0.35)
Bromide SCHEMBL3825715 0.97
Iodide SCHEMBL3654797 0.97
SCHEMBL2148332 0.97
Hydrochloric Acid SCHEMBL2706385 0.97
SCHEMBL27729 0.94
SCHEMBL3399160 0.92
SCHEMBL875158 0.91 CHRNA7 (0.32)
SCHEMBL13835555 0.89 CYP2D6 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2060 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070278-A Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof 标新生物医药科技(上海)有限公司 2026-05-19 CN claimed
EP-4709714-A1 SUBSTITUTED QUINOXALINES Mirati Therapeutics, Inc. (US) 2026-03-18 EP claimed
EP-4563146-A1 FLAVIVIRUS INHIBITORS IRBM S.P.A. (IT) 2025-06-04 EP claimed
US-20250154109-A1 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC 2025-05-15 US claimed
EP-4547666-A1 METHODS FOR TREATMENT OF CANCER Frontier Medicines Corporation (US) 2025-05-07 EP claimed
WO-2025029890-A1 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2025-02-06 WO claimed
US-12195445-B2 2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors MERCK SHARP & DOHME LLC (US) 2025-01-14 US claimed
CN-119233970-A Nitrogen-containing heterocyclic compound, and preparation method and application thereof 纽欧申医药(上海)有限公司 2024-12-31 CN claimed
EP-4472966-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2024-12-11 EP claimed
CN-119080773-A Organic amine-inorganic acid hybridization reversible phase change material and preparation method thereof 南昌大学 2024-12-06 CN claimed
EP-0307141-B1 OXAZOLES AND THIAZOLES FOR THE TREATMENT OF SENILE DEMENTIA MERCK SHARP &amp; DOHME LTD. (GB) 1993-01-13 EP claimed
EP-0492903-A1 Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma MERCK SHARP &amp; DOHME LTD. (GB) 1992-07-01 EP claimed
EP-0398617-A2 Process for resolving 1-azabicyclo [2.2.1]heptane-3-carboxylates MERCK SHARP & DOHME LTD. (GB) 1990-11-22 EP claimed
US-4952587-A PSYCHOLOGICAL DISORDERS, MIGRAINES, ALZHEIMER*S MERCK SHARP & DOHME LTD. (GB) 1990-08-28 US claimed
EP-0094742-B1 SUBSTITUTED AZABICYCLO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1990-08-01 EP claimed
US-4940703-A Spirocyclic compounds incorporating five-membered rings with two heteroatoms for treating psychotic disorders, etc. MERCK SHARP & DOHME LIMITED (GB) 1990-07-10 US claimed
EP-0350118-A2 Spiro-azabicyclic muscarinic agonists MERCK SHARP & DOHME LTD. (GB) 1990-01-10 EP claimed
EP-0337547-A1 Spirocyclic compounds incorporating five-membered rings with two heteroatoms MERCK SHARP & DOHME LTD. (GB) 1989-10-18 EP claimed
EP-0328200-A1 Five-membered ring systems with bonded azacyclic ring substituents MERCK SHARP & DOHME LTD. (GB) 1989-08-16 EP claimed
EP-0307141-A2 Oxazoles and thiazoles for the treatment of senile dementia MERCK SHARP &amp; DOHME LTD. (GB) 1989-03-15 EP claimed